Kantonsspital St.Gallen

A phase II, open label study to investigate the efficacy and safety of domatinostat in combination with avelumab in patients with advanced unresectable/metastatic Merkel Cell Carcinoma progressing on anti-PD-(L)1 antibody therapy – the MERKLIN 2 study

Antonio Cozzio

type of project clinical studies
status ongoing - recruiting phase
start of project 2022
end of project 2022
responsible person Antonio Cozzio